P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 13 December 2017 | 10:04 am

BASF opens its first automotive coatings production plant in Thailand

New production facility to serve growing demand for automotive coatings in ASEAN more ...

Published 13 December 2017 | 7:27 am

Sanofi presents R&D strategy and innovative pipeline

At least 10 pivotal phase 3 studies expected to begin over next 12 months more ...

Published 13 December 2017 | 7:27 am

Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma

High and durable response rate in disease without any FDA-approved therapies more ...

Published 12 December 2017 | 11:00 pm

U.S. Food And Drug Administration Extends Action Date For XELJANZ® (Tofacitinib) Supplemental New Drug Application In Ulcerative Colitis By Three Months

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has extended the action date by three months for the supplemental New Drug more ...

Published 12 December 2017 | 10:36 pm

Striving to Defeat Dengue with Effective Vaccines

Sanofi recently issued a global statement providing new data on our dengue vaccine that helps to further define the population that would best benefit from its protective value. more ...

Published 12 December 2017 | 6:56 pm

Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of YescartaTM (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma

-- 42 Percent of Patients Remained in Response, Including 40 Percent in Complete Remission, at a Median Follow-up of 15.4 Months -- more ...

Published 12 December 2017 | 6:50 pm

Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

-- Phase 1 Data for KTE-C19 Demonstrates High Rates of Response -- more ...

Published 12 December 2017 | 5:29 pm

GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US

First targeted treatment approved for this rare eosinophil-driven disease, following FDA Priority Review more ...

Published 12 December 2017 | 1:36 pm

Media Release

Roche announces phase III data showing Venclexta/Venclyxto plus MabThera/Rituxan reduced the risk of disease progression or death by 83% compared to a standard of care more ...

Published 11 December 2017 | 10:33 pm

Baxter to Present at the 36th Annual J.P. Morgan Healthcare Conference

DEERFIELD, Ill., December 11, 2017 - Baxter International Inc. (NYSE: BAX) will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 in more ...

Pharma Documentation Ring:
24 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Berlin, September 26 – 29, 2017

Next Annual General Meeting, Berlin, September 26 – 29, 2017